Brief: Roolife Group Says Execution Of MoU For Unit With Shanghai No.1 Pharmaceuticals
09/11/2023 10:34
Nov 9 (Reuters) - Roolife Group Ltd RLG.AX :
* EXECUTION OF MEMORANDUM OF UNDERSTANDING FOR UNIT WITH
SHANGHAI
NO.1 PHARMACEUTICALS CO
* MOU TO SOURCE AND DELIVER EXPANDED RANGE OF INTERNATIONAL
OTC
PHARMACEUTICALS, HEALTH, WELLNESS AND FOOD PRODUCTS
Source text for Eikon: ID:nASX1t8yts
Further company coverage: RLG.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Roolife
See all newsAustralia's RooLife Group jumps on renewable energy deal, premium placement
Brief: Roolife Says Aurora To Buy Renewable Energy Business Focused On Battery Storage And Hybrid Power
Brief: Roolife Group Requests Trading Halt
Brief: Roolife Group Says Jyotika Gondariya To Step Down As CFO
Brief: Roolife Group Posts Q2 Revenue of A$3.25 Million